| scholarly article | Q13442814 |
| P50 | author | Maurice J Ahsman | Q56862900 |
| Pavla Pokorná | Q57643532 | ||
| Dick Tibboel | Q88459455 | ||
| P2093 | author name string | John N Van den Anker | |
| Enno D Wildschut | |||
| Annewil van Saet | |||
| P2860 | cites work | Hypothermia-induced platelet aggregation in heparinized flowing human blood: identification of a high responder subpopulation | Q28192336 |
| Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support | Q28474209 | ||
| Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia | Q29615548 | ||
| Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest | Q29615549 | ||
| Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation | Q30303997 | ||
| Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates | Q30310834 | ||
| Extra-corporeal life support following cardiac surgery in children: analysis of risk factors and survival in a single institution. | Q30376064 | ||
| Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. | Q30381573 | ||
| Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. | Q30385121 | ||
| Physiologic and pharmacologic considerations for hypothermia therapy in neonates | Q30422782 | ||
| Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy | Q30437115 | ||
| Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation. | Q30472622 | ||
| Neonatal ECMO Study of Temperature (NEST)--a randomised controlled trial | Q33559118 | ||
| The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation | Q33710364 | ||
| Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation | Q33741966 | ||
| Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. | Q33826426 | ||
| Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers. | Q33861879 | ||
| Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation | Q34063554 | ||
| Therapeutic hypothermia for neonatal encephalopathy and extracorporeal membrane oxygenation | Q34079439 | ||
| Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
| Outcomes after extracorporeal cardiopulmonary resuscitation (ECPR) following refractory pediatric cardiac arrest in the intensive care unit | Q34263759 | ||
| Nosocomial infections during extracorporeal membrane oxygenation | Q34340902 | ||
| 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support | Q34519886 | ||
| Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium | Q34722105 | ||
| Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial | Q35003693 | ||
| Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. | Q35124226 | ||
| Pilot investigation of hypothermia in neonates receiving extracorporeal membrane oxygenation | Q35292908 | ||
| Evaluation of propofol infusion syndrome in pediatric intensive care | Q35553049 | ||
| Cardiac arrest and therapeutic hypothermia decrease isoform-specific cytochrome P450 drug metabolism. | Q35579550 | ||
| Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation | Q35825168 | ||
| Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation | Q35826801 | ||
| Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest | Q35840167 | ||
| Clinical outcomes of 84 children with congenital heart disease managed with extracorporeal membrane oxygenation after cardiac surgery | Q36328768 | ||
| Healthcare-associated infection in pediatric patients on extracorporeal life support: The role of multidisciplinary surveillance | Q36605920 | ||
| The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial | Q36693633 | ||
| Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: an analysis of the registry data of the extracorporeal life support organization | Q36806468 | ||
| A tertiary care center's experience with therapeutic hypothermia after pediatric cardiac arrest. | Q36845244 | ||
| An exploratory study with an adaptive continuous intravenous furosemide regimen in neonates treated with extracorporeal membrane oxygenation | Q36916305 | ||
| Practical pharmacologic aspects of therapeutic hypothermia after cardiac arrest. | Q37043548 | ||
| Induction and maintenance of therapeutic hypothermia after pediatric cardiac arrest: efficacy of a surface cooling protocol | Q37087896 | ||
| Predictors of outcome for children requiring respiratory extra-corporeal life support: implications for inclusion and exclusion criteria | Q37231786 | ||
| Extracorporeal cardiopulmonary resuscitation in refractory pediatric cardiac arrest | Q37233425 | ||
| Neonatal extracorporeal membrane oxygenation: practice patterns and predictors of outcome in the UK. | Q37284289 | ||
| Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration | Q37331411 | ||
| Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience. | Q37369971 | ||
| Anticoagulation and coagulation management for ECMO. | Q37600544 | ||
| Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. | Q37729124 | ||
| The effect of inflammation on drug metabolism: a focus on pediatrics | Q37849895 | ||
| Neurological complications of extracorporeal membrane oxygenation in children | Q37860307 | ||
| Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children | Q37872786 | ||
| Pharmacotherapy in neonatal and pediatric extracorporeal membrane oxygenation (ECMO). | Q37997475 | ||
| Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. | Q38000846 | ||
| Temperature and ionic influences on opiate receptor binding | Q39414065 | ||
| Nosocomial infections in neonates receiving extracorporeal membrane oxygenation | Q39443903 | ||
| Nicardipine to Control Neonatal Hypertension During Extracorporeal Membrane Oxygen Support | Q39647710 | ||
| Complications of hypothermia: interpreting 'serious,' 'adverse,' and 'events' in clinical trials | Q48206687 | ||
| The effect of critical illness and inflammation on midazolam therapy in children | Q48313391 | ||
| Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass | Q48473645 | ||
| Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients | Q48575819 | ||
| Is phenytoin administration safe in a hypothermic child? | Q48651756 | ||
| Moderate hypothermia in patients with severe head injury: cerebral and extracerebral effects | Q48912504 | ||
| High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children | Q48959555 | ||
| Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation | Q48972972 | ||
| Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial | Q49032647 | ||
| Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets | Q49304994 | ||
| Effects of temperature on bleeding time and clotting time in normal male and female volunteers | Q50113578 | ||
| Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. | Q50569629 | ||
| Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. | Q50588474 | ||
| Vecuronium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. | Q51369823 | ||
| Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic CPB in infants | Q51370823 | ||
| In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. | Q51417979 | ||
| Continuous infusion versus bolus administration of sufentanil and midazolam for mitral valve surgery. | Q51471674 | ||
| The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam. | Q51538294 | ||
| The FLACC: a behavioral scale for scoring postoperative pain in young children. | Q51542680 | ||
| Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ? | Q51568483 | ||
| Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. The Multicenter Study of Perioperative Ischemia Research Group. | Q51570552 | ||
| The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. | Q51594900 | ||
| Propofol sequestration within the extracorporeal circuit. | Q51629648 | ||
| Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. | Q51665064 | ||
| Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. | Q51705041 | ||
| Blood/gas solubility coefficient and blood concentration of enflurane during normothermic and hypothermic cardiopulmonary bypass | Q51714375 | ||
| Computerized Continuous Infusion of Intravenous Anesthetic Drugs During Pediatric Cardiac Surgery | Q51714517 | ||
| Pharmacokinetics of pancuronium in patients undergoing coronary artery surgery with and without low dose dopamine. | Q51722617 | ||
| In vitro variability in fentanyl absorption by different membrane oxygenators. | Q51733663 | ||
| Fentanyl intermittent bolus technique for anesthesia in infants and children undergoing cardiac surgery. | Q51750957 | ||
| Binding of fentanyl and alfentanil to the extracorporeal circuit. | Q51782113 | ||
| The influence of hypothermia on the disposition of fentanyl--human and animal studies. | Q51796964 | ||
| Sequestration of fentanyl by the cardiopulmonary bypass (CPBP). | Q51849405 | ||
| Effect of cardiopulmonary bypass on fentanyl distribution and elimination. | Q51870505 | ||
| Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. | Q51938979 | ||
| A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. | Q52016990 | ||
| Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. | Q52363936 | ||
| The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3-year-old infants. | Q52918951 | ||
| Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. | Q53974237 | ||
| Extracorporeal Circulation for Rewarming in Drowning and Near-Drowning Pediatric Patients | Q58869334 | ||
| Rapid-Response Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in Children With Cardiac Disease | Q59510283 | ||
| Amiodarone Treatment of Junctional Ectopic Tachycardia in a Neonate Receiving Extracorporeal Membrane Oxygenation | Q59615886 | ||
| Hypothermia and the pharmacokinetics and pharmacodynamics of pancuronium in the cat | Q67405394 | ||
| Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation | Q67590601 | ||
| Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy | Q67781763 | ||
| Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation | Q68076352 | ||
| Effects of acidosis, alkalosis, hyperthermia and hypothermia on haemostasis: results of point-of-care testing with the thromboelastography analyser | Q40387930 | ||
| Influence of hypo and hyperthermia on disposition of morphine | Q40783478 | ||
| Inactivation of heparin during extracorporeal circulation in infants | Q41236545 | ||
| Regulation of cytochromes P450 during inflammation and infection. | Q41676809 | ||
| Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium | Q41714746 | ||
| The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder | Q42115325 | ||
| Determinants of drug absorption in different ECMO circuits. | Q42362818 | ||
| Infections during extracorporeal life support | Q42681715 | ||
| Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: an open-label, prospective study. | Q42692190 | ||
| Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. | Q43060269 | ||
| Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy | Q43278567 | ||
| Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics | Q43612948 | ||
| Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass | Q44285138 | ||
| Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation | Q44296680 | ||
| Effects of temperature on the interaction of morphine with opioid receptors | Q44342217 | ||
| Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure | Q44405540 | ||
| Antibiotic prophylaxis with cefazolin and gentamicin in cardiac surgery for children less than ten kilograms | Q44405663 | ||
| Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation | Q44527488 | ||
| Accuracy of the 'Paedfusor' in children undergoing cardiac surgery or catheterization | Q44592705 | ||
| Drug metabolism in hypothermia. Uptake, metabolism and biliary excretion of pentobarbital-2-C14 by the isolated, perfused rat liver in hypothermia and euthermia | Q44617507 | ||
| Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia | Q44809448 | ||
| Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding | Q44827291 | ||
| Effect of hypothermia on the coagulation cascade | Q44931745 | ||
| Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. | Q45242702 | ||
| Acute respiratory distress syndrome following 2009 H1N1 virus pandemic: when ECMO come to the patient bedside | Q45378611 | ||
| Propofol requirement titrated to bispectral index: a comparison between hypothermic and normothermic cardiopulmonary bypass. | Q45945600 | ||
| Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. | Q45947465 | ||
| Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation | Q46121568 | ||
| Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation. | Q46213581 | ||
| Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children | Q46270016 | ||
| Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation | Q46364774 | ||
| The effect of mild hypothermia on plasma fentanyl concentration and biotransformation in juvenile pigs | Q46395548 | ||
| Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy | Q46670055 | ||
| Evaluation of plasma fentanyl concentrations in infants during cardiopulmonary bypass with low-volume circuits | Q46676294 | ||
| Hemodynamics among neonates with hypoxic-ischemic encephalopathy during whole-body hypothermia and passive rewarming | Q46970929 | ||
| Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit | Q47735874 | ||
| Therapeutic hypothermia: ready...fire...aim? How small feasibility studies can inform large efficacy trials | Q47790673 | ||
| Nesiritide during extracorporeal membrane oxygenation | Q47858755 | ||
| Fentanyl uptake by the scimed membrane oxygenator | Q47899698 | ||
| A pilot investigation of mild hypothermia in neonates receiving extracorporeal membrane oxygenation (ECMO). | Q47997911 | ||
| Cardiac arrhythmias associated with severe traumatic brain injury and hypothermia therapy | Q48200344 | ||
| Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation | Q68364752 | ||
| Vancomycin pharmacokinetics in infants undergoing extracorporeal membrane oxygenation | Q68580463 | ||
| Effects of hypothermia on drug absorption | Q68855406 | ||
| Cardiovascular effects of morphine during hypothermia | Q69625366 | ||
| Hypothermia-induced reversible platelet dysfunction | Q69742897 | ||
| Hypertension during extracorporeal membrane oxygenation: cause, effect, and management | Q69808209 | ||
| Pharmacokinetics of gentamicin in neonatal patients supported with extracorporeal membrane oxygenation | Q70134861 | ||
| The fate of phenobarbitone in children in hypothermia and at normal body temperature | Q70270797 | ||
| Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery | Q70684296 | ||
| UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group | Q71177552 | ||
| Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation | Q71310829 | ||
| Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia | Q71757319 | ||
| Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants | Q72048337 | ||
| Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization | Q72290370 | ||
| Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs | Q72595886 | ||
| Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs | Q73409701 | ||
| Extracorporeal life support outcome for 128 pediatric patients with respiratory failure | Q73490567 | ||
| Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation | Q73560093 | ||
| Usefulness of surveillance cultures in neonatal extracorporeal membrane oxygenation | Q73931313 | ||
| Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation | Q74592727 | ||
| Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity | Q74593077 | ||
| Hypertrophic obstructive cardiomyopathy in an infant of a diabetic mother: support by extracorporeal membrane oxygenation and treatment with beta-adrenergic blockade and increased intravenous fluid administration | Q77608247 | ||
| REDISTRIBUTION OF REGIONAL BLOOD FLOW IN HYPOTHERMIA | Q78255808 | ||
| Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment | Q80089048 | ||
| Enhanced platelet aggregation and activation under conditions of hypothermia | Q80158332 | ||
| Prolonged extracorporeal membrane oxygenation-assisted support provides improved survival in hypothermic patients with cardiocirculatory arrest | Q80853167 | ||
| Moderate hypothermia in neonatal encephalopathy: efficacy outcomes | Q81164710 | ||
| Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest | Q81369891 | ||
| Therapeutic hypothermia and pediatric cardiac arrests: vexing questions | Q82409408 | ||
| Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease | Q82975819 | ||
| Extended therapeutic hypothermia for several days during extracorporeal membrane-oxygenation after drowning and cardiac arrest Two cases of survival with no neurological sequelae | Q83198196 | ||
| Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia | Q83522322 | ||
| Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness | Q84577294 | ||
| Cefuroxime Pharmacokinetics in Pediatric Cardiovascular Surgery Patients Undergoing Cardiopulmonary Bypass | Q85073452 | ||
| P433 | issue | 5 | |
| P921 | main subject | hypothermia | Q1036696 |
| extracorporeal membrane oxygenation | Q1385195 | ||
| P304 | page(s) | 1183-1204 | |
| P577 | publication date | 2012-08-29 | |
| P1433 | published in | Pediatric Clinics of North America | Q7159204 |
| P1476 | title | The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children | |
| P478 | volume | 59 |
| Q89506195 | Clinical pharmacology considerations for children supported with ventricular assist devices |
| Q33950874 | Clinical pharmacology in neonates: small size, huge variability |
| Q38246000 | Drug metabolism for the paediatrician |
| Q55145216 | Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics. |
| Q36322918 | Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children |
| Q92718156 | Hypothermia: Impact on plasticity following brain injury |
| Q38992262 | Paracetamol and morphine for infant and neonatal pain; still a long way to go? |
| Q38829350 | Pharmacological sedation management in the paediatric intensive care unit |
| Q30249512 | Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review |
| Q38374584 | Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation. |
| Q28080112 | Sedation in Critically Ill Children with Respiratory Failure |
| Q38222870 | Tailored tools to improve pharmacotherapy in infants |
| Q34630847 | The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation |
Search more.